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ABSTRACT 
 
Background: Microcystic macular changes, also called microcystic macular oedema 
(MMO), have recently been reported in patients with multiple sclerosis (MS), 
particularly after optic neuritis. But it has since emerged that the finding is not specific 
for optic neuritis. This study was designed to prospectively investigate the prevalence of 
microcystic perifoveal changes in patients with optic atrophy not due to optic neuritis. 
 
Methods: A prospective, cross-sectional study including 54 patients with a history of 
optic atrophy. Spectral domain optical coherence tomography (SD-OCT) was used to 
scan the macular area and to measure the peripapillar retinal nerve fibre layer 
thickness. Scanning laser ophthalmoscopy (SLO) was used for imaging of the macular 
area. 
 
Results: Microcystic macular changes were present in 11/54 patients (20.4%), 17/90 
eyes with optic atrophy (18.9%) and absent in the normal eyes of patients with 
monocular optic atrophy. There was a trend for a higher prevalence of microcystic 
changes with longer duration of optic atrophy.  No correlations were found with the age, 
or severity of optic atrophy. Besides the known perifoveal (semi) circular abnormal 
reflexes on SLO imaging, we also noticed a more patchy pattern of low SLO reflections in 
some patients with optic atrophy.  
 
Conclusion: Microcystic macular changes are a frequent observation in patients with 
optic atrophy of another cause then optic neuritis. The cause of these abnormalities 
remains a matter of debate. It is important for clinicians to recognise these macular 
changes and to realise that the cause may lie remotely away from the macula. 
INTRODUCTION 
 
Recently, a new phenomenon of optical coherence tomography (OCT) imaging of the 
perifoveal region of the retina has been reported, with microcystic like changes in the 
inner nuclear layer (INL).[1] The term 'microcystic macular oedema (MMO)' was 
coined,[1] and subsequently translated to US spelling 'edema' as MME.[2] This new 
phenomenon drew a lot of attention in the neurological literature. Importantly, the 
microcystic changes were described in the retina of patients suffering from multiple 
sclerosis (MS) and were related to clinical and radiological disease activity.[1,3]  
The rapid recognition that these microcystic changes were not specific for MS stimulated 
an extensive exchange of letters.[4-7] Notably, microcystic changes were also seen in 
patients with non-MS types of optic neuritis, such as relapsing isolated optic neuritis 
(RION),[4] chronic relapsing optic neuropathy (CRION),[8,9] neuromyelitis optica ON 
(NMO-ON),[8] as well as aetiologies other then optic neuritis (ON).[5-7,10-14] It has also 
become apparent that microcystic macular changes occurred in ophthalmological 
degenerative diseases like age-related macular degeneration, diabetic retinopathy, 
vascular occlusion and with epiretinal membranes.[14,15] As the etiology of this retinal 
abnormality remains unknown and evidence for oedema not conclusively been 
provided, Kisimby et al. (2013) suggested to be careful about the terminology.[11] 
Therefore Abegg et al proposed to refer to a “retrograde maculopathy”.[13] 
Kisimbi et al. (2013) were also first to report that infrared imaging (IR) may be a 
convenient method to demonstrate the localisation of microcystic changes in the 
retina.[11] This has since been confirmed and scanning laser ophthalmoscopy (SLO) was 
added to the list more recently.[8,10,12,13] Taken together these imaging modalities 
consistently describe the microcysts to be distributed in a circular area, or semicircular 
area around the fovea.[8,10-13,16] An important limitation of all these observations was 
the retrospective study design resulting in a large variation of the reported prevalence, 
ranging from 0.8% to 25%.[3-8,10-15] In addition, there has been an inclusion bias 
towards ON and a publication bias of the neurological literature with the true clinical 
spectrum being much broader.[15]  
 
Therefore, the present study was designed to prospectively investigate the prevalence 
and epidemiology of microcystic paramacular changes in patients who did not suffer 
from ON and close the gap between the neurological and ophthalmological literature. 
 
 
METHODS 
 
Study design and patient population 
Patient and controls were enrolled at two Dutch university medical centres (Groningen, 
Amsterdam), between May 2013 and April 2014 for this cross-sectional study. The study 
was approved by the medical ethical committees and the scientific research committee 
at both centres. Written informed consent was obtained from all patients included. 
Patients were prospectively recruited either by referral to our tertiary care neuro-
ophthalmology service or own follow-ups. 
Inclusion criteria: All patients were older then 18 years of age, and had a history of optic 
nerve  atrophy. 
Exclusion criteria: optic neuritis due to multiple sclerosis (MSON), isolated optic neuritis 
(ION), relapsing isolated optic neuritis (RION), chronic relapsing inflammatory optic 
neuropathy (CRION), optic neuritis due to neuromyelitis optica (NMO-ON) and 
Harding's disease. An onset of optic atrophy of less then 4 months ago after AION, 
because of possible presence of subretinal oedema. We also excluded cases with intra-
ocular surgery in the past 6 months, previous radiotherapy to the visual pathways, 
diabetes mellitus, macular degeneration, retinal vein occlusion, retinal dystrophy, 
uveitis or retinal detachment. 
Clinical assessment: Demographic data and the medical history were obtained in all 
patients. Snellen visual acuities (VA) were recorded using high contrast charts.  
Spectral domain optical coherence tomography (SD OCT) 
Two SD OCT devices were used, a Canon OCT –HS100 in Groningen and a Heidelberg 
Spectralis in Amsterdam. Bot devices have a build in scanning laser ophthalmoscopy 
(SLO) camera and the eye tracking function was enabled as required for accurate 
quantitative OCT data assessment by maintaining eye alignment during image recording. 
In Groningen, multi-cross high resolution scans were made in horizontal and vertical 
direction through the macular area. In order to include the whole macular area, multi-
cross scans were made with a scan size of 3x3 mm and 10x10mm. We used a low 
averaging mode of 5 scans only, because in our experience these microcysts can be so 
small that they can be averaged out from the summary image.  Furthermore, a macular 
volume scan was made (10x10 mm), and a 3D scan of the optic disc area (6x6 mm), 
including an about 3.45 mm ringscan of the peripapillary retinal nerve fibre layer 
(pRNFL). The multicross scans and the macular volume scans were analysed for the 
presence of so-called MMO using validated criteria.[14] The quantitative pRNFL data 
served to grade the degree of optic atrophy seen by funduscopy. The normative database 
of the Canon OCT-HS100 was used for this purpose. The OCT scan divides the circle into 
four quadrants (temporal, superior, nasal, inferior) and gives the RNFL thickness for 
these sectors. For each eye, we calculated the mean value of these four quadrants to get 
an average RNFL thickness. 
 Likewise, in Amsterdam, an about 3.4 mm peripapillary ringscan was performed as well 
as two volume scans with vertically orientated OCT B-scans of a 20x20 degree field (25 
sections) for the macular and a 15 x 15 degrees field (73 sections) for the optic nerve 
head. 
Statistical analyses 
All statistical analyses were done in SPSS (version 22) and SAS (version 9.2). Normal 
distribution was checked graphically and using Shapiro-Wilk statistics. Normally 
distributed data were presented as mean and standard deviation (SD) and non-Gaussian 
data as median and interquartile range (IQR). Parametric and non-parametric testing 
was used according to normality. Categorical data were compared using the Fisher exact 
test.  
RESULTS 
Fifty-four patients were included with a mean age of 46.5 years (range 18 to 79 years). 
Twenty-four (44.4%) were female and twenty-eight (55.6%) male. Almost all patient 
were recruited by one centre (Groningen, n=52).  The ethnic background was Caucasian 
in 52, Asian in one, and Arabic in another patient. 
In all patients both eyes were imaged by SLO and OCT. Optic atrophy was binocular in 
37/54 (68.5%) patients and monocular in 17/54 (31.5%) patients. In all cases a pale 
disc on funduscopy corresponded to a pathological degree of pRNFL thinning.  
Table 1 summarises the aetiologies of optic atrophy in this study. The number of 
patients with microcystic macular changes in the different etiologic subgroups is also 
given.  
 
Microcystic changes were seen in 11/54 patients (20.4%). Considering individual eyes, 
microcystic changes were present in 17/90 eyes (18.9%) with optic atrophy. In four 
Table 1. Cause of optic atrophy in 54 patients  
 
n % of total 
Patients with 
microcystic macular 
changes 
Trauma 3 (5.6%) 2 
Compression 28 (51.9%) 3 
AION 10 (18.5%) 1 
Hereditary optic neuropathy 7 (1.9%) 3 
Metabolic/Toxic 1 (13.0%)  
Optic nerve head drusen 1 (1.9%)  
Intracranial hypertension 2 (3.7%) 1 
Unknown 2 (3.7%) 1 
patients microcystic changes were monocular, with one having evidence for bilateral 
optic atrophy. This patient suffered from a chiasmal glioma treated 13 years earlier. The 
eye showing MMO was the eye with poorer visual function as compared to the other eye 
(fig 3).  The other three patients had a monocular optic atrophy. Importantly, 
microcystic changes were never seen in absence of optic atrophy. There was one patient 
with bilateral microcystic changes and only a unilateral AION. A follow-up investigation 
revealed presence of burried optic disc drusen in the presumed healthy eye. This eye 
also showed a segmental thinning of the pRNFL on OCT. We rated this patient as having 
a binocular optic neuropathy. 
  OCT and SLO images 
Examples of OCT scans with microcystic macular changes together with SLO images are 
shown in figures 1-3. Figure 1 is the OCT and SLO image of the right and left eye of a 24 
years old patient who experienced a traumatic optic neuropathy of his left eye 10 month 
earlier. The OCT image of his right eye (Fig 1A) shows an intact RNFL (filled white 
arrow) at site of the inferior optic disc (Fig 1B). The OCT of the left eye (Fig 1 C) has no 
visible RNFL on the cross-section and a thinned ganglion cell layer (GCL) compared to 
the right eye. The open arrow points to the microcystic changes in the inner nuclear 
layer (INL). An enlargement of this area is shown in the insert image (Fig 1 D). 
Interestingly, hyperreflective dots were also seen in the INL far beyond the area of 
visible microcystic changes. A vertical OCT cross-section through the macular area is 
shown in the insert (Fig 1 F). The SLO image of the left eye (Fig 1 E) shows a C-shaped 
dark ring representing the area where the MMO was present on the OCT imaging. 
Figure 2 shows another two eyes of two patients with microcystic macular changes. The 
OCT image (Fig 2 A) is of a 62 years old patient with chiasmal compression 26 years ago 
due to a pituitary tumor, relieved by neurosurgical decompression at the time of 
diagnosis. The SLO image shows a circular pattern of abnormal dark reflection. The 
horizontal OCT scan through the macular area shows microcystic changes on both sides 
of the fovea, in concordance with the abnormal pattern of the SLO image in Figure 2 B. 
Again, hyperreflective dots were seen to involve a larger area than the microcysts (Fig 2 
A). The OCT image in Fig 2 C is of a 65 years old patient suffering from bilateral optic 
atrophy following a severe subarachnoid haemorrhage (SAH) with Terson syndrome 
and complications 10 years earlier. The aneurysmal SAH was Fisher grade IV and 
complicated by secondary hydrocephalus. Therefore, the bilateral optic atrophy was 
thought to be due to increased intracranial pressure.  We do not know about other 
possible complications associated with a poor grade SAH.[17] The horizontal OCT cross-
section through the macular area shows microcystic cysts on both sides of the fovea. The 
SLO image shows a more diffuse and patchy pattern of abnormal reflections. When 
scrolling through the OCT images, these abnormal areas of SLO reflections covered a 
larger area than the microcystic changes on OCT. As noted before, hyperreflective dots 
were also present in a larger area than microcystic changes involving several retinal 
layers.  
We made another observation not reported earlier on in relationship to microcystic 
macular changes. Figure 3 shows an OCT image of the right eye of a 25 years old man, 
who suffered from a chiasmatic glioma in his first year of life.  Visual fixation was not 
possible because of the very poor vision. Therefore the accidental eccentric scanning 
permitted to discover more peripheral microcystic changes of the INL. The approximate 
region of these microcystic changes is shown by the open arrow in the SLO image (Fig 
3). There was no abnormal reflection of the SLO image in this region. The INL also 
showed the typical thickening at the site of microcystic changes. As before, 
hyperreflective dots were seen adjacent to microcystic changes. Critical revision of the 
OCT scans from the darkened area on the SLO image did not reveal any visible 
microcystic changes. 
Correlation with age and disease duration 
There was no significant difference in the mean age between the patients without (46.7 
years, SD ±17.2 years) and with microcystic macular changes (46.3 years, SD ±15.3 
years) (T-test, p=0.095). Patients with microcystic macular changes had a longer 
duration of optic atrophy (median 155 months,  interquartile range 246 months) as 
compared to patients without microcystic macular changes (median 66 months, 
interquartile range 211 months), but this difference failed to reach statistical 
significance (Kruskal-Wallis test, p = 0.29). If we divide our study group in two equal 
groups of 27 patients according to the duration of optic atrophy, the first group with a 
duration of optic atrophy of 8 years or shorter had a microcystic macular changes 
prevalence of 11.1 % (3/27). In the second group of patients with a duration of optic 
atrophy of longer then 8 years the prevalence of MMO was 29.6% (8/27). This difference 
was not significant (Fisher exact test). 
Correlation with RNFL measurement 
Figure 4 shows box plot of the mean pRNFL thickness in the normal eyes of patients 
with monocular optic atrophy, the eyes with optic atrophy, but without microcystic 
macular changes and the eyes with microcystic macular changes. The groups were 
unbalanced and the data not Gaussian. General linear models showed a significant 
difference between groups (F2,89=46.01, p<0.0001) with a significant degree of atrophy 
in both groups (p<0.0001 for both, Fig 4) but no difference between those with and 
without microcystic changes.  
 
 
DISCUSSION 
The main outcome of this prospective study was that microcystic macular changes were 
present in 20.4% of the patients with optic atrophy not due to optic neuritis.  At first 
sight this appears to be substantially more compared to the pooled prevalence of 7.7% 
reported by Abegg et al. (2014).[6] Of note, the averaged disease duration was shorter in 
the Abegg study with 6.5 years compared to the 16 years in the present study. It is 
possible that the prevalence of microcystic changes might be higher with longstanding 
otpic atrophy, but prospective longitudinal data will be required to test this. The 
presence of microcystic changes in the context of hydrocephalus as described in one of 
our patients is consistent with another recent report on bilateral microcystic changes in 
a child with bilateral optic atrophy due to hydrocephalus (see Figure 5 in Tawse et al. 
(2014)).[18] 
From a clinical practice point of view it is relevant that microcystic macular changes are 
much more frequent with compressive aetiologies as compared to a recent episode of 
multiple sclerosis associated optic neuritis (MSON) 4.7- 6.3%.[1,8] The literature on 
other conditions is only emerging, but it might be prudent to consider neuroimaging if 
metabolic and heriditary conditions have been excluded and there is no other obvious 
ophthalmogical explanation. [5,11,14,15] 
There is clearly a need for future studies to longitudinally investigate the temporal and 
spatial profile of microcystic changes. Do microcystic changes appear earlier than for 
example the two to three months it takes for optic atrophy to develop after optic 
neuritis? Does the longitudinal profile help with the differential diagnosis of 
inflammatory and compressive pathologies? Does their spatial distribution change over 
time? There are no data at present to answer any of these pertinent questions. 
 
  
In the present study there was no difference in the mean age of patients with and 
without microcystic changes. This is in contrast with the study of Abegg et al. (2014) 
where they found that younger patients had a significant higher chance of having 
microcystic changes then older patients.[13] In our view it is difficult to attribute this to 
age alone and future prospective studies addressing this question will need to be careful 
to avoid an inclusion bias due to the age distribution of various aetiologies.  
It has been reported by several studies that the areas with microcystic changes in the 
macular area can also be detected by infrared or SLO fundus imaging. These areas of 
hyporeflection form a complete or incomplete ring around the parafoveolar area.[8,10-
13] A finding not previously reported in studies on microcystic changes is the patchy 
pattern of SLO abnormalities we found in the posterior pole of the retina in some 
patients with optic atrophy. In this context it might be relevant to follow-up on the 
observation made on hyperreflective dots adjacent to microcystic changes.[19] In all 
cases seen by us so far the area with microcystic changes was smaller compared to the 
area with hyperreflective dots. Scoles et al. (2014) made the important point that the 
Rayleigh resolution limits visibility. It may be possible that very small microcystic 
changes are just not visible on an individual OCT B-scan.[19] This argument led the John 
Hopkins group to develop an automated algorithm which possibly more accurately 
describes the spatial resolution of these microcystic changes.[20] It is therefore 
intriguing to note that microcystic changes were also not necessarily visible on all OCT 
B-scans were the focally darkened SLO image suggested their possible spatial 
distribution. 
A specific feature of SLO is the high degree of spatial sensitivity which makes it a good 
tool to identify areas with possible MMO. In addition, the spread areas of abnormal 
reflections on SLO imaging suggests that the degenerative changes might not be limited 
to the perifoveolar area. This is supported by another observation made in this study 
and shown in figure 3 where microcystic changes were detected just outside the 
perifoveolar area because of a serendipitous eccentric OCT scan in a patient who was 
not able to fixate. This is an area which is not routinely included in macular OCT 
imaging. 
The precise nature of the microcystic changes remains unknown. There have been no 
studies correlating OCT findings with histology. There are, however earlier histological 
observations which clearly demonstrate retinal vacuoles in the inner nuclear layer of the 
retina. [21,22] Retrograde axonal degeneration was the most probable mechanism in the 
macaccae model. An alternative mechanism, inflammation, was proposed with the 
recent OCT driven rediscovery of these microcystic changes in patients with MS.[1-3] 
But several studies have shown that there was no dye leakage on fluorescein 
angiography.[5,10] The data of the present study are more in keeping with the 
neurodegenerative hypothesis because inflammation was excluded and the long disease 
duration of 16 years. We and others have therefore drawn an analogy to the appearance 
of lesions on magnetic resonance imaging, appearing either as a T1 black hole 
representing neurodegeneration or a T2 lesion representing inflammation.[23] 
It has also been suggested that retrograde axonal degeneration influences the integrity 
of the retinal organisation and that loss of retinal Müller cell function may play a role in 
microcyst formation.[4,10,13,14,24] Finally, vitreo-retinal traction  can lead to the 
formation of microcystic changes,[5,7] but  certainly does not represent an unifying 
mechanism because it has conclusively shown to be absent in a number of cases.[25]  
 Taken together, the present study is the first prospective report on the prevalence of 
microcystic changes in patients with optic atrophy. The data show that microcystic 
changes are a frequent phenomena, particularly in the context of optic atrophy.  It is 
important for ophthalmologists to recognise these macular changes because they can be 
the result by pathology remotely located from the macula. Presence of microcystic 
macular changes should trigger pertinent questions and in absence of a history for optic 
neuritis or another evident aetiology one should consider imaging of the brain and 
orbits. 
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FIGURE LEGENDS 
Figure 1: A 24 years old patient with traumatic atrophy of his left eye.  (A) Horizontal 
OCT scan through macular area. The white filled arrow points to the intact nerve fibre 
layer. (B) SLO image of right eye. The striped line shows the approximate location of 
OCT scan in A. (C) Horizontal OCT scan of the eye with optic atrophy. Note the absence of 
visible retinal nerve fibre layer. The open arrow points to microcystic changes in the 
inner nuclear layer (INL). An enlargement of the area with changes is given in (D). (E) 
SLO image of left eye. Note the dark C-shaped ring around fovea. This represents the 
area where microcystic chages were found on horizontal scans and vertical scans (F) 
through the macular area. The white line in SLO image represents the approximate 
location of the vertical scan. 
 
Figure 2: (A) Horizontal OCT scan of the left eye of a 62 year old patient with chiasmal 
compression 26 years ago due to a pituitary tumor. The scan shows microcystic changes 
on both sides of the fovea. (B) SLO image of same eye showing a complete circle of 
abnormal reflection around the fovea (C) Horizontal OCT scan of the right eye of a 65 
year old patient who had optic atrophy due to increased intracranial pressure after a 
Fisher grade 4 subarachnoidal haemorrhage 10 years ago. (D) SLO image of the same 
eye, showing a patchy pattern of abnormal reflex in the macular area. 
 
Figure 3:  (A) OCT image of the right eye of a man who was treated for a chiasmatic 
glioma at the age of 12 years. Microcystic changes (open arrow) were found in a more 
peripheral region then normally reported. The approximate location of the horizontal 
OCT scan is given by the striped line in the SLO fundus image (B). The area with 
microcystic changes is given by the open arrow. 
 
Figure 4: Box plot of the mean pRNFL thickness in the normal eyes of patients with 
monocular optic atrophy, the eyes with optic atrophy but without microcystic macular 
changes and the eyes with optic atrophy and with microcystic changes. 
 
